The challenges of COVID‐19 Delta variant: Prevention and vaccine development-Reference-Cited by-同舟云学术

The challenges of COVID‐19 Delta variant: Prevention and vaccine development

Published:2021-10-19 Issue:4 Volume:2 Page:846-854
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

He Xuemei¹,He Cai¹,Hong Weiqi¹^ORCID,Zhang Kang²,Wei Xiawei¹^ORCID

Affiliation:

1. Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu Sichuan P. R. China

2. Center for Biomedicine and Innovations Faculty of Medicine Macau University of Science and Technology Taipa Macau P. R. China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.95

Reference69 articles.

1. Structures and distributions of SARS-CoV-2 spike proteins on intact virions

2. Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

4. New variants of SARS-CoV-2

5. Convergent evolution of SARS‐CoV‐2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID‐19 in Maharashtra, India;Cherian S;bioRxiv,2021

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A COMPREHENSIVE REVIEW ON THE MULTIFACETED INTERACTIONS BETWEEN HOST IMMUNITY AND VIRAL PATHOGENESIS IN COVID-19;International Journal of Applied Pharmaceutics;2024-07-07

2. Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies;Heliyon;2024-05

3. A Hybrid Metaheuristic Aware Modified Mobile Net with Enriched Feature Extraction for Covid-19 Severity Detection and Classification;Wireless Personal Communications;2024-05

4. Evaluation of antibody and T Cell immunity response in different immunization groups of inactive and mRNA COVID-19 vaccines;Diagnostic Microbiology and Infectious Disease;2024-01

5. Recent advances in chemometric modelling of inhibitors against SARS-CoV-2;Heliyon;2024-01